PCSK9 and hemorrhage: A retrospective study indicated that PCSK9 inhibitors in AIS patients undergoing post-mechanical thrombectomy may lead to improved discharge outcomes and decrease the occurrence of hemorrhage and early neurologic deterioration (32).